product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-BRCA1 (Ser1524) Antibody
catalog :
9009P
quantity :
40 ul
price :
123 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human
application :
western blot, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/DilutionReference
  • immunohistochemistry - paraffin section; human; 1:25; fig s1
Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  • western blot; human; 1:200; fig st1
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
Waye S, Naeem A, Choudhry M, Parasido E, Tricoli L, Sivakumar A, et al. The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging (Albany NY). 2015;7:854-68 pubmed
product information
SKU :
9009P
Product-Name :
Phospho-BRCA1 (Ser1524) Antibody
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
220
Host :
Rabbit
Target :
BRCA1 (Ser1524) phosphate
Primary-Protein :
BRCA1
Alt-Names :
BRCA1,BRCA1/BRCA2-containing complex, subunit 1,BRCAI,BRCC1,BROVCA1,Breast cancer type 1 susceptibility protein,IRIS,PSCP,RING finger protein 53,RNF53,breast and ovarian cancer susceptibility protein 1,breast and ovarian cancer sususceptibility protein,breast cancer 1, early onset
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.